FORMAN MARK S (Chief Medical Officer) sold 25.9% of their position (15.81K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $14.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2024ACC: 0001209191-24-000369
Officer· Chief Medical Officer
Since Mar 2022
-15.81K
Net shares
Net seller
$14.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 65.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
451.2%
12/31/2023
11.08K→61.08K
Common Stock
Direct
Shares
−15.81K
Price / share
$0.91
Trade value
$14.39K
% of position
25.9%
1/2/2024
61.08K→45.27K
Total
Net shares
+34.19K
Net value
-$14.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2023 | M · Option Exercise | +50K | — | — | 451.2% | 11.08K | 61.08K |
| Common Stock Direct | 1/2/2024 | S · Sale | −15.81K | $0.91 | $14.39K | 25.9% | 61.08K | 45.27K |
| Total | +34.19K | -$14.39K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
Held after
0.00
Exercisable
—
12/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock50K shares | 12/31/2023 | M · Option Exercise | −50K | — | 0.00 |